MKDTI: Predicting drug-target interactions via multiple kernel fusion on graph attention network
0
🌐
Sign in to get full access
Overview
- Researchers have developed computational models to predict drug-target relationships, which can help understand drug effects, improve drug development, and advance related research.
- Various structure-based, ligand-based, and network-based approaches have been explored, and the integration of graph attention networks with drug-target studies is an active area of interest.
- The authors propose a model called MKDTI that extracts kernel information from multiple layers of a graph attention network to improve the prediction of novel drug-target relationships.
Plain English Explanation
Drug companies and researchers are constantly looking for new ways to develop effective drugs. One promising approach is to use computational models to predict how drugs might interact with their targets (the molecules or cells they're designed to affect). This can help researchers understand how drugs work, speed up the drug development process, and advance related medical research.
The authors of this paper have developed a new model called MKDTI that uses a special type of neural network called a graph attention network to analyze the relationships between drugs and their targets. The model first builds a network that represents the connections between different drugs and targets, and then uses the graph attention network to identify important features of these connections.
The key innovation in the MKDTI model is that it combines information from multiple layers of the graph attention network to create a "kernel matrix" - a mathematical representation of the relationships between drugs and targets. This kernel matrix is then used to predict whether a new drug and target might interact with each other.
The authors tested their MKDTI model on real-world data and found that it outperformed other leading approaches for predicting drug-target interactions. This suggests that the multi-layer, multi-kernel approach of MKDTI can provide valuable insights that improve our ability to understand and predict how drugs will interact with their targets.
Technical Explanation
The authors first construct a drug-target heterogeneous network using various data sources on drugs and their targets. They then use a self-enhanced multi-head graph attention network to extract potential features from each layer of the network.
Next, the authors computationally extract kernel matrices from the embeddings of each layer, and fuse these multiple kernel matrices together. Finally, they use a Dual Laplacian Regularized Least Squares framework to predict novel drug-target connections based on the combined kernel matrix.
The authors measured the effectiveness of their MKDTI model using two common evaluation metrics: AUPR (area under the precision-recall curve) and AUC (area under the receiver operating characteristic curve). Compared to benchmark algorithms, the MKDTI model demonstrated superior performance in predicting drug-target interactions.
The authors also conducted an experiment on kernel selection, which showed that the multi-kernel fusion approach combined with the kernel matrix generated by the graph attention network provided complementary insights that helped enhance the accuracy of the predictions.
Critical Analysis
The paper provides a compelling approach for predicting drug-target interactions using a multi-layer, multi-kernel graph attention network. The authors demonstrate the effectiveness of their MKDTI model through rigorous experimentation and comparison to benchmark algorithms.
One potential limitation is that the model relies on the availability of high-quality heterogeneous data on drugs and their targets. In practice, such comprehensive data may not always be readily available, which could limit the applicability of the MKDTI approach.
Additionally, the authors do not delve into the interpretability of the MKDTI model - i.e., how the model arrives at its predictions and what specific insights it can provide about the underlying drug-target relationships. Further research into the model's interpretability could enhance its utility for drug discovery and development.
Despite these minor caveats, the MKDTI model represents a significant advancement in the field of drug-target interaction modeling and could have important implications for accelerating the drug development process and advancing related medical research.
Conclusion
The MKDTI model proposed in this paper demonstrates the power of integrating graph attention networks with multi-kernel fusion to predict novel drug-target relationships. By extracting and combining insights from multiple layers of a graph attention network, the model is able to outperform other leading approaches in predicting drug-target interactions.
This research underscores the potential of computational methods to enhance our understanding of pharmacological effects and accelerate the drug discovery and development process. As the field of drug-target interaction modeling continues to evolve, the MKDTI model and similar approaches could play a vital role in advancing medical research and improving patient outcomes.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
🌐
0
MKDTI: Predicting drug-target interactions via multiple kernel fusion on graph attention network
Yuhuan Zhou, Yulin Wu, Weiwei Yuan, Xuan Wang, Junyi Li
Drug-target relationships may now be predicted computationally using bioinformatics data, which is a valuable tool for understanding pharmacological effects, enhancing drug development efficiency, and advancing related research. A number of structure-based, ligand-based and network-based approaches have now emerged. Furthermore, the integration of graph attention networks with intricate drug target studies is an application area of growing interest. In our work, we formulate a model called MKDTI by extracting kernel information from various layer embeddings of a graph attention network. This combination improves the prediction ability with respect to novel drug-target relationships. We first build a drug-target heterogeneous network using heterogeneous data of drugs and targets, and then use a self-enhanced multi-head graph attention network to extract potential features in each layer. Next, we utilize embeddings of each layer to computationally extract kernel matrices and fuse multiple kernel matrices. Finally, we use a Dual Laplacian Regularized Least Squares framework to forecast novel drug-target entity connections. This prediction can be facilitated by integrating the kernel matrix associated with the drug-target. We measured our model's efficacy using AUPR and AUC. Compared to the benchmark algorithms, our model outperforms them in the prediction outcomes. In addition, we conducted an experiment on kernel selection. The results show that the multi-kernel fusion approach combined with the kernel matrix generated by the graph attention network provides complementary insights into the model. The fusion of this information helps to enhance the accuracy of the predictions.
Read more7/16/2024
🔮
0
A Cross-Field Fusion Strategy for Drug-Target Interaction Prediction
Hongzhi Zhang, Xiuwen Gong, Shirui Pan, Jia Wu, Bo Du, Wenbin Hu
Drug-target interaction (DTI) prediction is a critical component of the drug discovery process. In the drug development engineering field, predicting novel drug-target interactions is extremely crucial.However, although existing methods have achieved high accuracy levels in predicting known drugs and drug targets, they fail to utilize global protein information during DTI prediction. This leads to an inability to effectively predict interaction the interactions between novel drugs and their targets. As a result, the cross-field information fusion strategy is employed to acquire local and global protein information. Thus, we propose the siamese drug-target interaction SiamDTI prediction method, which utilizes a double channel network structure for cross-field supervised learning.Experimental results on three benchmark datasets demonstrate that SiamDTI achieves higher accuracy levels than other state-of-the-art (SOTA) methods on novel drugs and targets.Additionally, SiamDTI's performance with known drugs and targets is comparable to that of SOTA approachs. The code is available at https://anonymous.4open.science/r/DDDTI-434D.
Read more5/24/2024
0
RGDA-DDI: Residual graph attention network and dual-attention based framework for drug-drug interaction prediction
Changjian Zhou, Xin Zhang, Jiafeng Li, Jia Song, Wensheng Xiang
Recent studies suggest that drug-drug interaction (DDI) prediction via computational approaches has significant importance for understanding the functions and co-prescriptions of multiple drugs. However, the existing silico DDI prediction methods either ignore the potential interactions among drug-drug pairs (DDPs), or fail to explicitly model and fuse the multi-scale drug feature representations for better prediction. In this study, we propose RGDA-DDI, a residual graph attention network (residual-GAT) and dual-attention based framework for drug-drug interaction prediction. A residual-GAT module is introduced to simultaneously learn multi-scale feature representations from drugs and DDPs. In addition, a dual-attention based feature fusion block is constructed to learn local joint interaction representations. A series of evaluation metrics demonstrate that the RGDA-DDI significantly improved DDI prediction performance on two public benchmark datasets, which provides a new insight into drug development.
Read more8/29/2024
🔮
0
HiGraphDTI: Hierarchical Graph Representation Learning for Drug-Target Interaction Prediction
Bin Liu, Siqi Wu, Jin Wang, Xin Deng, Ao Zhou
The discovery of drug-target interactions (DTIs) plays a crucial role in pharmaceutical development. The deep learning model achieves more accurate results in DTI prediction due to its ability to extract robust and expressive features from drug and target chemical structures. However, existing deep learning methods typically generate drug features via aggregating molecular atom representations, ignoring the chemical properties carried by motifs, i.e., substructures of the molecular graph. The atom-drug double-level molecular representation learning can not fully exploit structure information and fails to interpret the DTI mechanism from the motif perspective. In addition, sequential model-based target feature extraction either fuses limited contextual information or requires expensive computational resources. To tackle the above issues, we propose a hierarchical graph representation learning-based DTI prediction method (HiGraphDTI). Specifically, HiGraphDTI learns hierarchical drug representations from triple-level molecular graphs to thoroughly exploit chemical information embedded in atoms, motifs, and molecules. Then, an attentional feature fusion module incorporates information from different receptive fields to extract expressive target features.Last, the hierarchical attention mechanism identifies crucial molecular segments, which offers complementary views for interpreting interaction mechanisms. The experiment results not only demonstrate the superiority of HiGraphDTI to the state-of-the-art methods, but also confirm the practical ability of our model in interaction interpretation and new DTI discovery.
Read more4/17/2024